ENV Stock Cash Flow Statements

Envestnet Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Envestnet Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2016-12-31	2015-06-30	2015-03-31	2014-09-30	2013-12-31	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30

cash flows from operating activities:
net income	-1,661,000	-79,201,000	539,000	-184,937,000	5,056,000	-23,132,000	-42,761,000	-37,841,000	-8,663,000	-24,268,000	-14,708,000	-5,310,000	11,438,000	-8,369,000	14,935,000	7,694,000	2,323,000	-5,471,000	-7,190,000	3,417,000	-2,964,000	613,000	-18,268,000	-512,000	2,511,000	-5,991,000	8,002,000		-1,320,000		2,536,000	2,511,000	3,768,000	695,000	541,000	-158,000	551,000	-668,000	740,000	1,829,000	1,925,000	2,447,000	1,404,000	867,000	625,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	35,530,000	45,733,000	33,892,000	29,246,000	34,311,000	33,806,000	32,941,000	33,340,000	33,408,000	32,182,000	31,618,000	29,515,000	29,850,000	30,010,000	28,392,000	28,584,000	28,951,000	28,443,000	27,683,000	28,104,000	26,735,000	26,915,000	19,517,000	19,332,000	19,563,000	19,185,000	19,546,000		15,492,000		5,725,000	5,333,000	4,253,000	4,663,000	3,118,000	3,384,000	3,393,000	3,224,000	2,399,000	1,700,000	1,550,000	1,578,000	1,548,000	1,493,000	1,451,000
non-cash compensation expense	16,484,000	17,822,000	18,898,000	12,890,000	17,298,000	21,390,000	19,453,000	17,750,000	17,265,000	23,504,000	21,814,000	17,713,000	18,885,000	17,285,000	14,137,000	13,916,000	15,852,000	13,884,000	15,985,000	17,277,000
non-cash interest expense	1,420,000	-1,763,000	4,580,000	-1,785,000	4,571,000	-2,247,000	4,498,000	2,009,000	1,962,000	875,000	2,599,000	910,000	1,983,000	891,000	2,015,000	6,260,000	6,348,000	1,444,000	4,463,000	2,051,000	7,299,000	3,016,000	6,880,000	2,197,000	6,707,000	2,421,000	3,209,000		3,858,000
non-cash goodwill impairment	0
non-cash gain on deconsolidation	0
non-cash convertible promissory note impairment
income from equity method investments	1,526,000
fair market value adjustments to investments in private companies
lease related impairments				2,637,000	0
other	-3,293,000	42,000	2,078,000	626,000	851,000	407,000	-103,000	36,000	152,000	226,000	-59,000	216,000	-33,000	117,000	165,000	-1,285,000	0			2,600,000	-1,200,000	-1,000,000	-1,000,000
changes in operating assets and liabilities:
fees receivable	19,391,000	6,028,000	-18,841,000	-10,963,000	12,736,000	-778,000	-21,579,000	-6,577,000	-12,148,000	5,033,000	8,661,000	21,299,000	-36,696,000	-1,807,000	473,000	-4,230,000	-2,265,000	5,773,000	-14,333,000	-5,025,000	6,700,000	-1,734,000	1,198,000		-927,000	1,987,000	-10,191,000								-1,683,000	1,504,000	-2,061,000	540,000	1,034,000	1,396,000	102,000	-125,000	567,000	-1,373,000
prepaid expenses and other assets	-2,199,000	-3,374,000	-2,371,000	5,961,000	-10,772,000	3,096,000	-9,858,000
accounts payable, accrued expenses and other liabilities	28,267,000	26,610,000	-40,659,000	21,077,000	-19,548,000	50,617,000	-32,917,000
deferred revenue	-6,007,000	94,000	2,400,000	4,703,000	-3,122,000	-8,925,000	8,073,000	2,024,000	-6,606,000	-6,820,000	11,097,000	-1,015,000	-3,854,000	-5,093,000	7,882,000	-5,613,000	-5,748,000	1,638,000	5,598,000	-504,000	-2,709,000	-3,099,000	7,039,000	-802,000	-2,331,000	-3,578,000	7,056,000		-1,078,000		1,890,000	4,088,000	645,000	871,000	461,000	428,000	126,000	23,000	451,000	-388,000	11,000	34,000	-164,000	151,000
net cash from operating activities	95,355,000	89,110,000	1,944,000	75,591,000	40,009,000	72,789,000	-33,521,000	30,802,000	33,593,000	49,381,000	3,261,000	80,603,000	50,815,000	69,350,000	49,809,000	38,157,000	66,656,000	56,035,000	8,988,000	46,881,000	59,454,000	14,966,000	-12,575,000	34,071,000	42,360,000	41,707,000	-753,000	37,004,000	36,059,000	24,935,000			16,932,000	14,272,000	3,755,000	9,452,000	9,223,000	4,936,000	4,930,000	5,913,000	6,163,000	7,637,000	5,008,000	5,448,000	1,867,000
capex	-19,143,000	-22,070,000	-20,504,000	-23,910,000	-26,955,000	-35,459,000	-26,048,000	-24,456,000	-28,683,000	-26,619,000	-25,567,000	-24,098,000	-21,644,000	-21,039,000	-22,120,000	-17,915,000	-19,049,000	-16,300,000	-13,732,000	-14,196,000	-15,349,000	-8,398,000	-12,432,000	-9,893,000	-14,508,000	-10,604,000	-9,587,000	0	-5,810,000	0			0	0	-1,370,000	-1,392,000	-1,809,000	-3,028,000	-959,000	-888,000	-1,658,000	-1,880,000	-1,854,000	-1,169,000	-986,000
free cash flows	76,212,000	67,040,000	-18,560,000	51,681,000	13,054,000	37,330,000	-59,569,000	6,346,000	4,910,000	22,762,000	-22,306,000	56,505,000	29,171,000	48,311,000	27,689,000	20,242,000	47,607,000	39,735,000	-4,744,000	32,685,000	44,105,000	6,568,000	-25,007,000	24,178,000	27,852,000	31,103,000	-10,340,000	37,004,000	30,249,000	24,935,000			16,932,000	14,272,000	2,385,000	8,060,000	7,414,000	1,908,000	3,971,000	5,025,000	4,505,000	5,757,000	3,154,000	4,279,000	881,000
cash flows from investing activities:
purchases of property and equipment	-767,000	-3,272,000	-1,900,000	-720,000	-1,540,000	-12,333,000	-4,402,000	-3,058,000	-3,973,000	-5,245,000	-3,896,000	-7,952,000	-4,422,000	-4,295,000	-7,062,000	-3,264,000	-4,495,000	-2,169,000	-2,160,000	-3,749,000	-7,283,000
capitalization of internally developed software	-18,376,000	-18,798,000	-19,953,000	-23,190,000	-24,316,000	-23,137,000	-23,664,000	-21,398,000	-24,710,000	-21,374,000	-21,671,000	-16,146,000	-17,222,000	-16,744,000	-15,058,000	-14,651,000	-14,554,000	-14,131,000	-11,572,000	-10,447,000	-8,066,000	-8,398,000	-7,185,000	-6,457,000	-6,989,000	-6,023,000	-4,599,000		-3,559,000						-765,000	-652,000	-710,000	-642,000	-346,000	-347,000	-318,000	-382,000	-435,000	-378,000	-322,000
deconsolidation of non-controlling interest	0
investments in private companies	0	-250,000	-2,805,000	0	-2,725,000	-500,000	-950,000	0	-8,351,000	-5,000,000	-3,000,000	-17,000,000	-4,377,000	-2,011,000	-2,538,000	-1,765,000	-1,250,000	-925,000	-11,700,000
acquisition of proprietary technology	-1,481,000			-5,000,000	0	-2,000,000	-10,000,000	0	0	0	-15,000,000	0	0	0	-25,517,000
issuance of loan receivable to private company				0	0	0	-20,000,000
net cash from investing activities	-20,624,000	-36,393,000	-24,658,000	-28,896,000	-28,500,000	-37,911,000	-58,756,000	-24,371,000	-128,747,000	-51,941,000	-46,067,000	-41,098,000	-25,672,000	-59,193,000	-50,175,000	-16,783,000	-20,299,000	-17,225,000	-45,689,000	-11,190,000	-16,549,000	-323,476,000	-24,493,000	-12,021,000	-21,122,000	-20,366,000	-188,170,000	-6,927,000	-7,260,000	-20,239,000					-1,370,000	-2,278,000	-1,808,000	-65,548,000	-73,000	-24,602,000	-1,652,000	-2,040,000	-1,839,000
cash flows from financing activities:
proceeds from borrowings on revolving credit facility					15,000,000											0	0	0	45,000,000	170,000,000	0			0	0	0	195,000,000		10,000,000
payments related to revolving credit facility				0	-35,000,000
payments related to convertible notes					0
proceeds from exercise of stock options	357,000	653,000	71,000	769,000	367,000	105,000	367,000	61,000	1,817,000	84,000	658,000	1,170,000	347,000	51,000	522,000	2,707,000	1,370,000	3,275,000	3,408,000	3,563,000	2,115,000	1,751,000	3,163,000	106,000	2,659,000	136,000	2,404,000		1,851,000		2,199,000	3,710,000	1,531,000	822,000	56,000	142,000	362,000	617,000	948,000	45,000	442,000	1,188,000	1,072,000	582,000	93,000
payments related to tax withholdings for stock-based compensation	-3,692,000	-3,706,000	-8,449,000	-2,018,000	-3,230,000	-3,042,000	-10,732,000
payments related to share repurchases				0	0	0	-9,289,000
proceeds from capital contributions received by non-controlling interest	0	0	12,012,000
purchase of non-controlling units from third-party shareholders				0	0	0	-1,008,000
net cash from financing activities	-3,334,000	-3,053,000	3,637,000	4,263,000	-27,581,000	-28,576,000	-20,812,000	-82,552,000	-709,000	-17,509,000	-26,232,000	-4,014,000	-848,000	-12,138,000	-12,170,000	96,000	223,984,000	-15,341,000	24,211,000	-24,597,000	-48,722,000	140,438,000	-6,654,000	113,318,000	-1,323,000	67,189,000	173,110,000	-18,871,000	-7,712,000	-2,766,000	6,112,000	8,739,000	27,110,000	1,661,000	-150,000	1,676,000	318,000	3,376,000	870,000	45,000	442,000	1,188,000	978,000	-180,000	39,617,000
effect of exchange rate on changes on cash and cash equivalents	-8,000	4,000	-2,000
net change in cash and cash equivalents	71,389,000	60,741,000	-30,152,000
cash and cash equivalents, beginning of period	0	0	91,378,000																										0		0	209,754,000	0	0	29,983,000	0	0	0	64,909,000	0	0	0	67,668,000	0	0
cash and cash equivalents, end of period	71,389,000	60,741,000	61,226,000																									11,411,000	20,974,000	1,930,000	-10,987,000	209,914,000	41,435,000	13,259,000	32,218,000	8,850,000	7,733,000	-57,236,000	70,636,000	-18,644,000	4,953,000	6,785,000	71,815,000	4,103,000	40,735,000
supplemental disclosures of cash flow information
net cash paid for income taxes	7,077,000	5,530,000	568,000	2,314,000	10,329,000	2,113,000	1,110,000
cash paid for interest	3,117,000	7,861,000	1,509,000	7,870,000	1,631,000	8,778,000	1,822,000
supplemental disclosure of non-cash activities
conversion of equity method investee loan to shares				0	0	0	4,129,000	0	0
right-of-use assets obtained in exchange for lease liabilities				1,036,000	-21,000	174,000	206,000
purchases of property and equipment included in accounts payable, accrued expenses and other liabilities
purchase of property and equipment included in accounts payable, accrued expenses and other liabilities			1,349,000		-1,099,000	11,000	2,018,000
deferred income taxes			-855,000	-21,000	-936,000	-5,743,000	5,221,000	890,000	3,842,000	10,733,000	-18,955,000	-7,398,000	-1,059,000	11,718,000	-3,581,000	-1,963,000	1,677,000	-11,000	-1,587,000	-2,004,000	-8,635,000	-29,160,000	169,000	-1,775,000	-4,761,000	830,000	-17,923,000		122,000		-1,080,000	1,888,000			-570,000	645,000	-130,000	-444,000	12,000	-632,000	677,000	1,342,000	775,000	506,000	551,000
loss allocations from equity method investments			2,283,000	2,339,000	2,368,000	2,932,000	2,940,000	3,542,000	2,387,000	1,400,000	1,545,000
net change in cash and cash equivalents due to cash reclassified to assets held for deconsolidation			-11,073,000
goodwill impairment
fair market value adjustment to investment in private company				2,000,000								0	0
dilution gain on equity method investee share issuance				0	0				0
loss on extinguishment of convertible notes due 2023
gain on extinguishment of convertible notes due 2025
loss on property and equipment disposals
payments of contingent consideration												0	0	-1,360,000	-1,000,000					0	0								0
fair market value adjustment to contingent consideration liability												0	-927,000	0	-140,000	-1,049,000	-74,000
gain on settlement of liability												0
acquisitions of businesses, net of cash acquired								85,000	-89,713,000			0	349,000			0	0	0	-20,257,000	656,000	0
issuance of note receivable to equity method investees
proceeds from borrowings under revolving credit facility
settlement of convertible notes due 2023
proceeds from issuance of convertible notes due 2027
convertible notes due 2027 issuance costs
repurchase of convertible notes due 2023
repurchase of convertible notes due 2025
payments related to capped call transactions
proceeds from capital contributions of non-controlling shareholders
effect of exchange rate on changes on cash, cash equivalents and restricted cash				-2,791,000	264,000	53,000	3,580,000
net change in cash, cash equivalents and restricted cash				48,167,000	-15,808,000	6,355,000	-109,509,000
cash, cash equivalents and restricted cash, beginning of period				0	0	0	162,173,000	0	0	0	429,428,000	0	0	0	384,714,000	0	0	0	82,755,000	0	0	0	289,671,000			0	62,115,000
cash, cash equivalents and restricted cash, end of period				48,167,000	-15,808,000	6,355,000	52,664,000	-79,157,000	-96,934,000	-21,499,000	359,763,000	35,480,000	24,275,000	-2,453,000	372,126,000	21,648,000	270,674,000	23,623,000	68,769,000	10,873,000	-6,161,000	-168,018,000	246,061,000			88,067,000	46,193,000
supplemental disclosure of cash flow information
purchase of fixed assets included in accounts payable and accrued expenses and other current liabilities
treasury stock purchases included in accrued expenses and other liabilities
membership interest liabilities included in other liabilities
common stock issued to settle purchase liability																				0	0	0	772,000
internally developed software costs included in accrued expenses and other liabilities										450,000	178,000	-469,000
leasehold improvements funded by lease incentive												0	0	37,000	127,000	40,000			894,000			159,000	489,000						1,817,000							0				0				0	0
purchase liabilities included in accrued expenses and other liabilities																0			375,000							-11,750,000	13,172,000		19,000
release of uncertain tax positions									0
loss on property and equipment disposals - office closures									0
payments on finance lease obligations					-4,719,000	-640,000	-152,000
property and equipment acquired through finance lease					4,719,000	640,000	152,000
internally developed software costs included in accounts payable, accrued expenses and other liabilities
benefit from doubtful accounts							571,000	979,000	762,000	517,000	-1,747,000	-453,000	1,596,000	157,000	298,000	494,000	808,000	489,000	1,026,000	1,612,000	530,000	262,000	451,000	390,000	304,000	463,000	461,000		487,000					50,000	60,000									0	0
membership interest liabilities included in other non-current liabilities								0	0	628,000	124,000	123,000	125,000	124,000	124,000	124,000			2,220,000	2,220,000	2,220,000
operating activities:
accretion on contingent consideration and purchase liability												74,000	81,000	187,000	388,000	380,000	398,000	311,000	599,000	532,000	498,000	502,000	240,000	13,000	13,000	95,000	101,000		104,000
gain on equity method investments
lease related impairments, including right-of-use assets
changes in operating assets and liabilities, net of acquisitions:
prepaid expenses and other current assets								11,474,000	-5,889,000	5,656,000	-8,377,000	-170,000	724,000	-1,911,000	1,756,000	1,473,000	-3,383,000	-963,000	-6,793,000	-1,656,000	10,723,000	-2,161,000	-13,346,000	3,852,000	-1,313,000	239,000	-3,665,000		-2,635,000				1,511,000		-169,000	1,561,000	4,100,000	-1,919,000	903,000	-1,116,000	-450,000	58,000	-480,000	571,000
other non-current assets								-1,078,000	-276,000	-2,524,000	-1,114,000	-2,113,000	1,189,000	572,000	3,093,000	-156,000	-1,454,000	-994,000	641,000	879,000	-2,872,000	-2,181,000	-1,060,000	-448,000	-438,000	11,000	-2,461,000		-1,270,000						-241,000	6,000	-261,000			71,000				-134,000
accrued expenses and other liabilities								-1,543,000	8,794,000	-4,642,000	-27,320,000	26,628,000	26,110,000	29,195,000	-28,668,000	18,716,000	7,877,000	7,070,000	-11,554,000	8,921,000	9,328,000	15,435,000	-34,495,000	6,229,000	12,158,000	11,956,000	-17,404,000		14,041,000
accounts payable								-2,857,000	-2,235,000	1,800,000	-432,000	-2,832,000	1,789,000	-4,111,000	6,444,000	-12,271,000	14,214,000	1,075,000	-3,205,000	3,996,000	-2,091,000	-9,947,000	5,179,000	-2,357,000	-66,000	2,572,000	1,594,000		1,619,000		1,251,000	188,000	809,000	1,023,000	-122,000	95,000	-164,000	417,000	292,000	-39,000	255,000	-298,000	349,000	-53,000
other non-current liabilities								6,723,000	-251,000	-933,000	-1,361,000	1,999,000	-990,000	1,760,000	-1,068,000	-8,046,000	138,000	2,091,000	-145,000	1,553,000	640,000	1,748,000	854,000	568,000	693,000	206,000	1,372,000		-1,170,000				134,000	114,000	-66,000	987,000	63,000	71,000	45,000	-243,000	72,000	72,000	60,000	36,000
investing activities:
advance for technology solutions								0	0			0	0
issuance of notes receivable to equity method investees								0	-2,000,000
financing activities:
proceeds from issuance of convertible notes due 2025																0
convertible notes due 2025 issuance costs																0
payments on revolving credit facility																0	-275,000,000	-15,000,000	-15,000,000	-10,000,000	-45,000,000			0	0	-261,168,000	-15,000,000		-17,500,000
capital contributions - non-controlling shareholders													3,178,000
payments of deferred consideration on prior acquisitions																0
purchase of capped calls
taxes paid in lieu of shares issued for stock-based compensation								-2,903,000	-2,500,000	-5,543,000	-12,570,000	-3,215,000	-4,294,000	-3,479,000	-9,541,000	-3,218,000
share repurchases								-76,515,000	0			-1,904,000	0
finance lease payments								-4,138,000	-27,000	-2,063,000	-12,454,000
effect of exchange rate changes on cash								-3,036,000	-1,071,000	-1,430,000	-627,000	-11,000	-20,000	-472,000	-52,000	178,000	333,000	154,000	-1,496,000	-221,000	-344,000	54,000	112,000	455,000	-475,000	-463,000	-109,000		-113,000
increase in cash, cash equivalents and restricted cash								-79,157,000				35,480,000	24,275,000			21,648,000	270,674,000			10,873,000	-6,161,000			135,823,000	19,440,000
supplemental disclosure of cash flow information - net cash paid during the period for income taxes								4,204,000	2,456,000	4,744,000	716,000	2,025,000	2,818,000	1,198,000	1,879,000	2,955,000			814,000	293,000	1,705,000	1,123,000	4,998,000
supplemental disclosure of cash flow information - cash paid during the period for interest								3,195,000	2,260,000	3,337,000	2,254,000	3,338,000	2,261,000	3,333,000	2,200,000	3,338,000			2,740,000	5,717,000	1,861,000	5,736,000	216,000			2,297,000	1,974,000		927,000		1,569,000	65,000
supplemental disclosure of non-cash operating, investing and financing activities:
contingent consideration issued in acquisition of businesses																0			5,239,000	-100,000	0
purchase of fixed assets included in accounts payable and accrued expenses and other liabilities								2,836,000	-938,000	425,000	1,883,000	879,000	-383,000	-297,000	1,129,000	737,000			1,752,000	-430,000	695,000	1,208,000	359,000						245,000
property and equipment acquired through financing leases
transfer of non-controlling units																0
lease related impairments, including right of use assets
revolving credit facility issuance costs									0	-3,000	-1,869,000									0
purchase liabilities included in other non-current liabilities													-349,000						257,000	0	0	0	5,468,000
fixed assets acquired through finance lease									865,000	2,063,000	12,454,000
assets obtained in exchange for lease liabilities									2,201,000				3,388,000
impairment of right of use assets												0	427,000			1,235,000	0
decrease in cash, cash equivalents and restricted cash										-21,499,000	-69,665,000				-12,588,000				-13,986,000				-43,610,000				-15,922,000
gain on acquisition of equity method investment																0	0	0	-4,230,000
loss allocation from equity method investments												1,540,000	1,508,000	757,000	3,288,000	1,119,000	994,000	1,256,000	2,030,000
gain on life insurance proceeds
proceeds from life insurance policy
payment of convertible notes due 2019
capital contribution - non-controlling interest
common stock issued in acquisition of business																				0	0
right of use assets in exchange for lease liabilities
share repurchase															-1,672,000
deferred rent and lease incentive amortization																								263,000	-661,000	684,000	385,000
proceeds from issuance of convertible notes due 2023																								0	0
convertible notes due 2023 issuance costs																								0	-494,000
issuance of common stock and warrants - private placement, net of offering costs
purchase of ers units
issuance of restricted stock units																1,000	0	1,000	2,000	1,000	1,000	1,000	2,000	0	1,000	1,000	2,000		0
transaction costs of issuance of common stock and warrants included in accrued expenses and other liabilities
accrued payment to fund deferred compensation liability included in accounts payable																											1,551,000
purchase of treasury stock for stock-based tax withholdings																		-3,617,000	-9,199,000	-3,410,000	-3,735,000	-6,143,000	-9,819,000	-2,932,000	-3,489,000	-5,099,000	-9,296,000		-1,969,000
loss allocation from equity method investment																				854,000	957,000	347,000	203,000	77,000	258,000	151,000	660,000		282,000
investment in private companies
payments of definite consideration																													0
payments of purchase consideration liabilities																													0
payment of term notes																													0
non-cash debt issuance costs
non-cash based compensation expense
stock-based compensation expense																							12,864,000	10,671,000	10,603,000	10,476,000	8,495,000		8,048,000
purchase of property and equipment																							-5,247,000	-3,436,000	-7,519,000	-4,581,000	-4,988,000		-2,251,000						-605,000	-740,000	-1,099,000	-2,386,000	-613,000	-541,000	-1,340,000	-1,498,000	-1,419,000	-791,000	-664,000
acquisition of business																							-11,061,000
contingent consideration issued in business acquisition																							7,580,000
fair market value adjustment to contingent consideration
impairment of equity method investment
loss on disposal of fixed assets																								132,000	47,000	0	10,000		0
fees and other receivables																													-647,000
acquisition of businesses																								342,000	-6,614,000	-9,762,000	-178,583,000										0							0
common stock acquired under the share repurchase program
contingent consideration issued in business acquisitions
supplemental disclosure of cash flow information - net cash paid (refunded) during the period for income taxes																											1,359,000
purchase of fixed assets included in accrued expenses and other liabilities																											1,331,000
effect of exchange rate on changes on cash
net increase in cash and cash equivalents
fair market value adjustment on contingent consideration
investment in private company
acquisition of businesses, net of cash acquired
debt issuance costs
decrease in cash and cash equivalents																													20,974,000
supplemental disclosure of cash flow information - net cash refunded (paid) during the period for income taxes																													1,174,000
contingent consideration issued in a business acquisition
deferred rent and lease incentive																															51,000	168,000	-950,000		20,000	23,000	4,000	1,373,000	-11,000		467,000	-41,000	-69,000
excess tax benefits from stock-based compensation expense																															4,027,000	11,468,000	1,883,000
accretion on contingent consideration																															309,000	342,000
payment on revolving credit facility
issuance of redeemable units in ers
purchase of treasury stock for stock-based minimum tax withholdings
stock and stock options issued in acquisition of business
purchase liabilities included in accrued expenses
purchase of fixed assets included in accounts payable
tax shortfall (excess tax benefit) from stock-based compensation expense
excess tax benefit (shortfall) from stock-based compensation expense
increase in cash and cash equivalents																																160,000	41,435,000	13,259,000	2,235,000	8,850,000	7,733,000	-57,236,000	5,727,000	-18,644,000	4,953,000	6,785,000	4,147,000	4,103,000
purchase consideration liabilities included in accrued expenses and other liabilities
impairment of long-lived assets
excess tax benefits from stock-based compensation																																			-160,000
interest expense																															2,341,000	2,356,000					0	0	3,000		206,000	204,000	211,000	243,000	193,000
proceeds from issuance of convertible notes
convertible notes issuance costs
proceeds from issuance of term notes
payment of promissory note
proceeds from exercise of warrants																																		0										0	20,000
supplemental disclosure of cash flow information - cash paid during the period for income taxes, net of refunds																															316,000	475,000	136,000		416,000
common stock issued in business acquisitions
attribution of the fair market value of replacement awards
issuance of promissory note for acquisition
settlement of contingent consideration liability upon issuance of ers, llc membership interest																																	0
stock-based compensation																															3,330,000	3,419,000		2,457,000	2,306,000	1,217,000	1,195,000	1,135,000	795,000	703,000	714,000	829,000	816,000	623,000	584,000
accrued expenses																																		4,443,000	260,000	1,309,000	2,407,000	1,117,000	-1,733,000	361,000	322,000	1,331,000	-1,212,000	1,286,000
issuance of restricted stock																															0	2,000		0		0	0
acquisition of business, net of cash acquired
acquired purchase option
imputed interest expense																																	284,000
proceeds from bank indebtedness
payment of contingent consideration
issuance of ers, llc redeemable units
contingent consideration liability issued in acquisition of business
amortization of customer inducements																																								948,000	1,207,000	1,207,000	1,206,000	1,307,000	1,146,000
loss on investments
impairment of customer inducement asset
contract settlement charges
customer inducements																																								0	0			0
repayment of notes payable assumed in acquisition																																				0	0
purchase of treasury stock																																			-367,000	-15,000	-44,000	0	-78,000	0	0	0	-94,000	-762,000	-1,216,000
supplemental disclosure of non-cash investing and financing activities:
non-cash consideration issued in a business acquisition
supplemental disclosure of cash flow information:
cash paid during the period for income taxes, net of refunds
contigent consideration liability issued in acquisition of business
issuance of common stock - vesting of restricted stock																																			1,000
gain on investments
proceeds from repayment of notes receivable																																												0	857,000
increase in notes receivable																																												0	-8,000
proceeds from investments																																				3,000	1,000	6,000	-3,000	5,000	6,000	2,000	15,000	4,000	5,000
net proceeds from issuance of common stock																																												0
preferred stock dividends																																												0
supplemental disclosure of cash flow information – cash paid during the period for income taxes, net of refunds
issuance of warrant for customer inducement																																												0	0
customer inducement payable																																												1,693,000
note payable assumed in a business acquisition																																												0	0
goodwill - working capital settlement																																					0
supplemental disclosure of cash flow information - cash paid during the period for:
income taxes																																					279,000	-16,000	341,000	81,000	341,000	282,000	109,000	65,000	49,000
goodwill adjustment																																							889,000
amortization of deferred rent and lease incentive																																												-70,000	-68,000
impairment of investments
write-off of customer inducement asset
changes in operating assets and liabilities, net of effect of acquisitions:
repayment of notes payable																																								0	0
investments in non-marketable securities
supplemental disclosure of cash flow information – cash paid during the period for:
purchase of non-marketable securities
exercise of redemption rights into note receivable
unrealized (gain) loss on investments
proceeds from issuance of preferred stock
net proceed from issuance of common stock
unrealized gain on investments																																										-1,000	-3,000
net cash (used in) investing activities																																												-1,165,000	-749,000
net proceeds from issuance of preferred stock
contingent consideration issued in a business combination
unrealized (gain) on investments
increase in fees receivable
increase in prepaid expenses and other current assets
increase in other non-current assets
increase in customer inducements
increase in accrued expenses
increase in accounts payable
increase in deferred revenue
increase in other non-current liabilities
customer inducement - other

We provide you with 20 years of cash flow statements for Envestnet stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Envestnet stock. Explore the full financial landscape of Envestnet stock with our expertly curated income statements.

The information provided in this report about Envestnet stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.